Search by Drug Name or NDC
NDC 44567-0410-24 Magnesium Sulfate in Dextrose 1 g/100mL Details
Magnesium Sulfate in Dextrose 1 g/100mL
Magnesium Sulfate in Dextrose is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by WG Critical Care, LLC. The primary component is MAGNESIUM SULFATE HEPTAHYDRATE.
Product Information
NDC | 44567-0410 |
---|---|
Product ID | 44567-410_2bb880cf-2841-4c1a-a72a-5cf5e506a41c |
Associated GPIs | 79400010412032 |
GCN Sequence Number | 063498 |
GCN Sequence Number Description | magnesium sulfate/D5W PIGGYBACK 1 G/100 ML INTRAVEN |
HIC3 | C1H |
HIC3 Description | MAGNESIUM SALTS REPLACEMENT |
GCN | 99224 |
HICL Sequence Number | 006306 |
HICL Sequence Number Description | MAGNESIUM SULFATE/DEXTROSE 5 % IN WATER |
Brand/Generic | Generic |
Proprietary Name | Magnesium Sulfate in Dextrose |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Magnesium Sulfate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 1 |
Active Ingredient Units | g/100mL |
Substance Name | MAGNESIUM SULFATE HEPTAHYDRATE |
Labeler Name | WG Critical Care, LLC |
Pharmaceutical Class | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA207349 |
Listing Certified Through | 2024-12-31 |
Package
NDC 44567-0410-24 (44567041024)
NDC Package Code | 44567-410-24 |
---|---|
Billing NDC | 44567041024 |
Package | 24 BAG in 1 CARTON (44567-410-24) / 100 mL in 1 BAG |
Marketing Start Date | 2016-03-08 |
NDC Exclude Flag | N |
Pricing Information | N/A |